World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 88 13174 12400 41 40 610 28082

Dae Seog Heo publications per year

The chart shows the history of publications by Dae Seog Heo between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Dae Seog Heo published across 39 years, from 1987 to 2025, averaging 17.7 papers a year. Output peaked at 49 publications in 2023. 35 of the 690 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 49. Peak 49 publications in 2023. 1987: 1 publication 1988: 1 publication 1989: 1 publication 1990: 1 publication 1991: 2 publications 1992: 1 publication 1993: 2 publications 1994: 3 publications 1995: 2 publications 1996: 1 publication 1997: 4 publications 1998: 6 publications 1999: 9 publications 2000: 11 publications 2001: 15 publications 2002: 12 publications 2003: 17 publications 2004: 30 publications 2005: 30 publications 2006: 20 publications 2007: 22 publications 2008: 23 publications 2009: 30 publications 2010: 22 publications 2011: 32 publications 2012: 40 publications 2013: 38 publications 2014: 34 publications 2015: 36 publications 2016: 36 publications 2017: 31 publications 2018: 21 publications 2019: 36 publications 2020: 13 publications 2021: 15 publications 2022: 8 publications 2023: 49 publications 2024: 26 publications 2025: 9 publications
1987 2025

690 publications in total across all disciplines

View publications per year as a table
Dae Seog Heo: publications per year, 1987 to 2025
Year Publications
1987 1
1988 1
1989 1
1990 1
1991 2
1992 1
1993 2
1994 3
1995 2
1996 1
1997 4
1998 6
1999 9
2000 11
2001 15
2002 12
2003 17
2004 30
2005 30
2006 20
2007 22
2008 23
2009 30
2010 22
2011 32
2012 40
2013 38
2014 34
2015 36
2016 36
2017 31
2018 21
2019 36
2020 13
2021 15
2022 8
2023 49
2024 26
2025 9
Total 690
Download as CSV

Dae Seog Heo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dae Seog Heo sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 601–620 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 610 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396 610
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Dae Seog Heo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dae Seog Heo sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 88–89 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970 88
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Dae Seog Heo is a researcher affiliated with Seoul National University Hospital in South Korea, with a primary focus in the field of Medicine. Their work spans various subfields, notably Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, and Molecular Biology.

The researcher has contributed to several topics centered on cancer and patient care. Key areas of their research include:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Palliative Care and End-of-Life Issues
  • Lymphoma Diagnosis and Treatment
  • Patient Dignity and Privacy
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics

Dae Seog Heo has published extensively, with frequent contributions in specific academic journals and venues. These include:

  • Cancer Research and Treatment
  • Korean Journal of Sports Science
  • Scientific Reports
  • Journal of Korean Medical Science
  • Research Square (Research Square)

Recent papers authored or coauthored by the researcher illustrate the range and focus of their scientific inquiries. Some of these include:

  • "Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment", 2021, Scientific Reports
  • "Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines", 2020, Journal for ImmunoTherapy of Cancer
  • "Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma", 2020, Theranostics
  • "Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma", 2020, Leukemia
  • "Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab", 2021, CHEST Journal

The researcher frequently collaborates with a set of coauthors, reflecting a network of scientific partnerships. Frequent coauthors include:

  • Bhumsuk Keam
  • Tae Min Kim
  • Dong-Wan Kim
  • Miso Kim
  • Shin Hye Yoo

Best Publications

  • Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

    Vincent A. Miller;Vincent A. Miller;Vera Hirsh;Jacques Cadranel;Yuh Min Chen

  • Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

    Sae-Won Han;Tae-You Kim;Pil Gyu Hwang;Soohyun Jeong

  • Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies.

    Tae You Kim;Dong-Wan Kim;Jae-Yong Chung;Sang Goo Shin

  • Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

    June Chul Lee;Kyung Mi Lee;Dong Wan Kim;Dae Seog Heo

  • Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.

    June Koo Lee;Junehawk Lee;Sehui Kim;Soyeon Kim

  • Validation of the Korean version of the EORTC QLQ-C30.

    Y.H. Yun;Y.S. Park;E.S. Lee;S.-M. Bang

  • Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer

    Dong-Wan Kim;Dong-Wan Kim;S. Y. Kim;H. K. Kim;S. W. Kim

  • Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan-Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

    Suresh S. Ramalingam;Fiona Blackhall;Maciej Krzakowski;Carlos H. Barrios

  • Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

    Sae-Won Han;Tae-You Kim;Yoon Kyung Jeon;Pil Gyu Hwang

  • Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

    Primo N Lara;Jean Yves Douillard;Kazuhiko Nakagawa;Joachim Von Pawel

  • Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis.

    Bhumsuk Keam;Seock-Ah Im;Kyung-Hun Lee;Sae-Won Han

  • Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer

    Joon Oh Park;Sang-We Kim;Jin Seok Ahn;Cheolwon Suh

  • Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

    Chan Young Ock;Bhumsuk Keam;Sehui Kim;Ju Seog Lee

  • Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

    Se Hoon Lee;J. K. Lee;M. J. Ahn;D. W. Kim

  • Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer

    D. Y. Kim;Joo Hang Kim;S. H. Lee;T. Y. Kim

  • Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal type

    Tae Min Kim;Tae Min Kim;Yeon Hee Park;Yeon Hee Park;Sang-Yoon Lee;Sang-Yoon Lee;Ji-Hoon Kim;Ji-Hoon Kim

  • Mechanisms of Acquired Resistance to AZD9291: A Mutation-Selective, Irreversible EGFR Inhibitor.

    Tae Min Kim;Tae Min Kim;Ahnah Song;Dong-Wan Kim;Dong-Wan Kim;Soyeon Kim

  • MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma

    Jin Ho Paik;Ji-Young Jang Jang;Yoon Kyung Jeon;Wook Youn Kim

  • Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer†

    Sae-Won Han;Pil Gyu Hwang;Doo Hyun Chung;Dong-Wan Kim

  • Elevated TGF-b1 Secretion and Downmodulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

    June-Chul Lee;Yong-Oon Ahn;Dong-Wan Kim;Dae Seog Heo

Frequent Co-Authors

Dong-Wan Kim
Dong-Wan Kim Seoul National University Hospital
Se-Hoon Lee
Se-Hoon Lee Sungkyunkwan University
Yung-Jue Bang
Yung-Jue Bang Seoul National University
Seock-Ah Im
Seock-Ah Im Seoul National University Hospital
Yoon Kyung Jeon
Yoon Kyung Jeon Seoul National University Hospital
Doo Hyun Chung
Doo Hyun Chung Seoul National University
Young Tae Kim
Young Tae Kim Seoul National University Hospital
Woo Ho Kim
Woo Ho Kim Seoul National University
Dong-Young Noh
Dong-Young Noh Seoul National University
Keunchil Park
Keunchil Park The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean becoming a doctor. The United States offers a variety of online degree programs in healthcare fields that can open doors to rewarding roles in medicine. Many students look for the whats the easiest nursing program to get into? as an accessible first step into nursing, providing foundational skills and career mobility.

For those interested in the administrative side of healthcare, online programs are available, such as a healthcare administration associate degree online. This pathway offers fast-track options for entry-level management roles in clinics and hospitals.

Financial assistance is crucial for many students. You can explore medical billing and coding schools that accept fafsa if you’re interested in the technical aspects of healthcare but need help funding your studies.

If standardized exams are a concern, research whether do i need to take the teas test for lpn applies to your desired nursing program—some accredited options have no exam requirements.

Exploring these alternative online healthcare degrees and pathways can help you find the right fit for your interests, budget, and timeline.

Best Scientists Citing Dae Seog Heo

Trending Scientists

Recently Published Articles